Showing 1 - 10 of 2,198
Persistent link: https://www.econbiz.de/10010486640
Persistent link: https://www.econbiz.de/10012062660
Persistent link: https://www.econbiz.de/10012208686
Persistent link: https://www.econbiz.de/10014533487
environmental, social and governance (ESG) content, materiality and assurance mechanisms in their corporate disclosures. Very often …, the organisations integrate financial, social and sustainability reporting. In this light, this chapter provides a … disclosures. Afterwards, it describes the International Integrated Reporting Council's IR Framework and its guiding principles …
Persistent link: https://www.econbiz.de/10012867812
' environmental, social and governance (ESG) disclosures, and explain the purpose of integrated thinking and reporting … corporate communication. This research explores the GRI's latest Sustainability Reporting Standards as it sheds light on IIRC's …
Persistent link: https://www.econbiz.de/10012914518
This study aims to analyse the diffusion level of non-financial reporting (sustainability reporting, corporate social … responsibility, and integrated reporting) in companies listed on the Indonesia Stock Exchange and analyse the quality of sustainable … reporting standalone. Indonesia, which is one of the emerging market countries, has not yet established independent sustainable …
Persistent link: https://www.econbiz.de/10014452013
symposiums on environmental and social reporting issues for their board members and employ directors from a diverse educational … reporting of listed consumer goods in Nigeria. for the period 2014-2019. We developed a sustainability disclosure index using … the Global Reporting Initiative (GRI) guidelines to score the information content of annual reports relating to …
Persistent link: https://www.econbiz.de/10014361781
engagement in the reporting process, in particular in the materiality analysis, to achieve a high level of materiality …
Persistent link: https://www.econbiz.de/10012865118
Novo Nordisk is one of the few highly reputed pharma businesses and there is a reason for it. Rather than stick to its economistic origins that so many of its competitors live and organize by, Novo Nordisk allowed itself to experiment and react to stakeholder criticism. Rather than reactively...
Persistent link: https://www.econbiz.de/10014197723